Orchid Pharma Limited

NSE ORCHPHARMA.NS

Orchid Pharma Limited EBITDA for the year ending March 31, 2024: USD 17.01 M

Orchid Pharma Limited EBITDA is USD 17.01 M for the year ending March 31, 2024, a -2.16% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Orchid Pharma Limited EBITDA for the year ending March 31, 2023 was USD 17.39 M, a 107.69% change year over year.
  • Orchid Pharma Limited EBITDA for the year ending March 31, 2022 was USD 8.37 M, a -6.92% change year over year.
  • Orchid Pharma Limited EBITDA for the year ending March 31, 2021 was USD 9.00 M, a 24.47% change year over year.
  • Orchid Pharma Limited EBITDA for the year ending March 31, 2020 was USD 7.23 M, a -75.62% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
SV Wall Street
NSE: ORCHPHARMA.NS

Orchid Pharma Limited

CEO Mr. Rajnish Rohatgi B. Tech.
IPO Date July 1, 2002
Location India
Headquarters Orchid Towers
Employees 871
Sector Healthcare
Industries
Description

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company's multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. In addition, the company provides liaising support to customers in regulatory, pharma covigilance, testing and release, retention of samples, service providers, and business development. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited is a subsidiary of Dhanuka Laboratories Limited.

Similar companies

SOLARA.NS

Solara Active Pharma Sciences Limited

USD 6.08

-1.96%

JUBLPHARMA.NS

Jubilant Pharmova Limited

USD 11.39

-5.33%

PANACEABIO.NS

Panacea Biotec Limited

USD 4.72

-3.66%

GLAND.NS

Gland Pharma Limited

USD 17.27

-0.27%

StockViz Staff

February 8, 2025

Any question? Send us an email